Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

About the Linvoseltamab Clinical Development Program Linvoseltamab is an investigational BCMAxCD3 bispecific antibody designed to bridge B-cell maturation antigen (BCMA) on MM cells with ...

Sanofi in partnership with Regeneron to present 24 abstracts across approved and investigational medicines at AAAAI Annual Meeting in San Diego: Paris Friday, February 7, 2025, 12 ...

It was my birthday, July 25th; have always loved going to Chili's. We were seated in the bar area & right away I was met with a fly at the table. Little did I know (until I noticed) there were ...

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report fourth-quarter and full-year 2024 results on Feb. 4, ...

Earnings Call Transcript January 30, 2025 Sanofi misses on earnings expectations. Reported EPS is $0.7 EPS, expectations were $0.71. Thomas Larsen: Welcome to the Q4 and Full Year 2024 Conference Call ...

Obviously, Dupixent in COPD has a broader label ... Of course, any decision is subject to regulatory final active review. And then with respect to the label and monitoring, I think you'll see ...

One primary reason is the strong performance and potential of Dupixent, which is expected to partially counterbalance the uncertainties surrounding Eylea. The expected growth in Dupixent’s ...

The Galaxy A34 5G is an all-plastic affair, including the rear cover and frame, though there are individual cutouts in the rear cover for the triple camera system. My first impression was that the ...

The latest Clio is a good-value small car that's fun to drive and has a smart interior We’re used to the Renault Clio having image changes like they're going out of fashion, and the latest ...

I’ve been writing and editing technology content for over seven years, most recently as part of PCMag's software team. I am responsible for the creativity, education, operating system ...